DTC
NKTR icon

Deep Track Capital’s Nektar Therapeutics NKTR Stock Holding History

Deep Track Capital’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-33,333
Closed -$2.69M – 56
2022
Q1 		$2.69M Hold
33,333
– – 0.17% 49
2021
Q4 		$6.75M Buy
+33,333
New +$7.23M 0.48% 47

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deep Track Capital's NKTR Position: Q2 2026 in Review

Deep Track Capital opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 300,000 shares worth $20.9M. The stake represents 0.3% of the portfolio and ranks #57 among its holdings. This is a return to the name: Deep Track Capital previously reported a position in NKTR as recently as Q4 2024.

Deep Track Capital first reported a position in NKTR in Q1 2023 and has held it in 9 quarters since. The position peaked at $22.2M in Q2 2024. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Deep Track Capital held 300,000 shares of Nektar Therapeutics worth $20.9M as of Q2 2026.
  • Nektar Therapeutics was a new Deep Track Capital position in Q2 2026.
  • Nektar Therapeutics made up 0.3% of Deep Track Capital's portfolio in Q2 2026, its #57 holding.
  • Deep Track Capital first reported a position in Nektar Therapeutics in Q1 2023 and has held it in 9 quarters since.
  • Deep Track Capital's Nektar Therapeutics position peaked at $22.2M in Q2 2024.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.